Serina Therapeutics, Inc.SERNYSE
Loading
Interest Expense Over TimeContracting
Percentile Rank67
3Y CAGR+26.3%
5Y CAGR-39.8%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+26.3%/yr
Annual compound
5Y CAGR
-39.8%/yr
Recent acceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$32000.00-93.9%
2024$526000.00-5.7%
2023$558000.00+3414.3%
2022$15878.00+413.2%
2021$3094.00-99.2%
2020$404000.00-
2019$0.00-
2018$0.00-100.0%
2017$12000.00-52.0%
2016$25000.00-